[go: up one dir, main page]

ITMI931673A1 - Uso della benzidamina nel trattamento di stati patologici causati dal tnf - Google Patents

Uso della benzidamina nel trattamento di stati patologici causati dal tnf

Info

Publication number
ITMI931673A1
ITMI931673A1 IT93MI001673A ITMI931673A ITMI931673A1 IT MI931673 A1 ITMI931673 A1 IT MI931673A1 IT 93MI001673 A IT93MI001673 A IT 93MI001673A IT MI931673 A ITMI931673 A IT MI931673A IT MI931673 A1 ITMI931673 A1 IT MI931673A1
Authority
IT
Italy
Prior art keywords
benzidamine
tnf
treatment
pathological states
states caused
Prior art date
Application number
IT93MI001673A
Other languages
English (en)
Inventor
Valerio Cioli
Original Assignee
Angelini Francesco Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Francesco Ist Ricerca filed Critical Angelini Francesco Ist Ricerca
Publication of ITMI931673A0 publication Critical patent/ITMI931673A0/it
Priority to IT93MI001673A priority Critical patent/IT1276040B1/it
Priority to DE69428797T priority patent/DE69428797T2/de
Priority to HU9600182A priority patent/HU226805B1/hu
Priority to RO96-00144A priority patent/RO117149B1/ro
Priority to PT94923739T priority patent/PT711163E/pt
Priority to CA002167926A priority patent/CA2167926C/en
Priority to ES94923739T priority patent/ES2163450T3/es
Priority to EP94923739A priority patent/EP0711163B1/en
Priority to CZ96255A priority patent/CZ285864B6/cs
Priority to AU73861/94A priority patent/AU692458B2/en
Priority to PCT/EP1994/002343 priority patent/WO1995003799A1/en
Priority to SK105-96A priority patent/SK281895B6/sk
Priority to AT94923739T priority patent/ATE207353T1/de
Priority to RU96105062/14A priority patent/RU2160102C2/ru
Priority to PL94312741A priority patent/PL312741A1/xx
Priority to JP50552795A priority patent/JP3587851B2/ja
Priority to SI9430373T priority patent/SI0711163T1/xx
Priority to US08/586,804 priority patent/US6300358B1/en
Priority to NZ269563A priority patent/NZ269563A/en
Priority to DK94923739T priority patent/DK0711163T3/da
Priority to ZA945431A priority patent/ZA945431B/xx
Publication of ITMI931673A1 publication Critical patent/ITMI931673A1/it
Priority to NO960347A priority patent/NO308195B1/no
Priority to LVP-96-46A priority patent/LV11524B/en
Priority to BG100385A priority patent/BG62841B1/bg
Priority to CN94193377A priority patent/CN1085528C/zh
Application granted granted Critical
Publication of IT1276040B1 publication Critical patent/IT1276040B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso della benzidamina e dei suoi sali di addizione acida fisiologicamente accettabili per preparare un medicamento per il trattamento di stati patologici causati dal TNF.
IT93MI001673A 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf IT1276040B1 (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IT93MI001673A IT1276040B1 (it) 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf
AT94923739T ATE207353T1 (de) 1993-07-27 1994-07-14 Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
PL94312741A PL312741A1 (en) 1993-07-27 1994-07-14 Application of benidamine in treatment of pathologies caused by tnf
RO96-00144A RO117149B1 (ro) 1993-07-27 1994-07-14 Metoda de tratament a unei stari patologice cauzate de factorul de necroza tumorala
PT94923739T PT711163E (pt) 1993-07-27 1994-07-14 Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf
CA002167926A CA2167926C (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf
ES94923739T ES2163450T3 (es) 1993-07-27 1994-07-14 Utilizacion de benzidamina en el tratamiento de estados patologicos causados por tnf.
EP94923739A EP0711163B1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf
CZ96255A CZ285864B6 (cs) 1993-07-27 1994-07-14 Použití benzydaminu pro léčení patologických stavů způsobených TNF
AU73861/94A AU692458B2 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by TNF
PCT/EP1994/002343 WO1995003799A1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf
SK105-96A SK281895B6 (sk) 1993-07-27 1994-07-14 Použitie benzydamínu na prípravu liečiva na liečenie patologických stavov spôsobených tumor necrosis factorom
DE69428797T DE69428797T2 (de) 1993-07-27 1994-07-14 Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
RU96105062/14A RU2160102C2 (ru) 1993-07-27 1994-07-14 Применение бензидамина для лечения патологических состояний, вызванных фно
HU9600182A HU226805B1 (en) 1993-07-27 1994-07-14 Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf
JP50552795A JP3587851B2 (ja) 1993-07-27 1994-07-14 Ｔｎｆ誘発病状の治療におけるベンジダミンの使用
SI9430373T SI0711163T1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf
US08/586,804 US6300358B1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by TNF
NZ269563A NZ269563A (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by TNF
DK94923739T DK0711163T3 (da) 1993-07-27 1994-07-14 Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
ZA945431A ZA945431B (en) 1993-07-27 1994-07-22 Use of benzydamine in the treatment of pathological conditions caused by TNF
NO960347A NO308195B1 (no) 1993-07-27 1996-01-26 Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF
LVP-96-46A LV11524B (en) 1993-07-27 1996-02-15 Use of benzydamine in the treatment of pathological conditions caused by tnf
BG100385A BG62841B1 (bg) 1993-07-27 1996-02-26 Използване на бензидамин за лечение на патологичнисъстояния, причинени от туморнекрозен фактор
CN94193377A CN1085528C (zh) 1993-07-27 1996-07-14 炎痛静在治疗由tnf引起的病理疾病中的用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001673A IT1276040B1 (it) 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf

Publications (3)

Publication Number Publication Date
ITMI931673A0 ITMI931673A0 (it) 1993-07-27
ITMI931673A1 true ITMI931673A1 (it) 1995-01-27
IT1276040B1 IT1276040B1 (it) 1997-10-24

Family

ID=11366694

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93MI001673A IT1276040B1 (it) 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf

Country Status (25)

Country Link
US (1) US6300358B1 (it)
EP (1) EP0711163B1 (it)
JP (1) JP3587851B2 (it)
CN (1) CN1085528C (it)
AT (1) ATE207353T1 (it)
AU (1) AU692458B2 (it)
BG (1) BG62841B1 (it)
CA (1) CA2167926C (it)
CZ (1) CZ285864B6 (it)
DE (1) DE69428797T2 (it)
DK (1) DK0711163T3 (it)
ES (1) ES2163450T3 (it)
HU (1) HU226805B1 (it)
IT (1) IT1276040B1 (it)
LV (1) LV11524B (it)
NO (1) NO308195B1 (it)
NZ (1) NZ269563A (it)
PL (1) PL312741A1 (it)
PT (1) PT711163E (it)
RO (1) RO117149B1 (it)
RU (1) RU2160102C2 (it)
SI (1) SI0711163T1 (it)
SK (1) SK281895B6 (it)
WO (1) WO1995003799A1 (it)
ZA (1) ZA945431B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2201736C1 (ru) * 2001-12-24 2003-04-10 Закрытое акционерное общество "Брынцалов-А" Ушные капли бротинум
CN101199515B (zh) * 2007-12-21 2010-12-08 重庆市莱美药物技术有限公司 盐酸苄达明洗剂及其制备方法
AU2010213936B2 (en) * 2009-02-10 2014-07-31 Celgene Corporation Methods of using and compositions comprising PDE4 modulators for treatment, prevention and management of tuberculosis
PL2451452T3 (pl) * 2009-07-08 2016-03-31 Acraf Zastosowanie benzydaminy do leczenia chorób zależnych od p40
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054833A (it) * 1963-08-09
US4980160A (en) * 1986-10-16 1990-12-25 Biogen, Inc. Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases
GB8807803D0 (en) * 1988-03-31 1988-05-05 Glaxo Group Ltd Biochemical product
IL95031A (en) * 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release

Also Published As

Publication number Publication date
ES2163450T3 (es) 2002-02-01
PT711163E (pt) 2002-04-29
BG62841B1 (bg) 2000-09-29
US6300358B1 (en) 2001-10-09
CZ285864B6 (cs) 1999-11-17
NZ269563A (en) 2001-03-30
CA2167926A1 (en) 1995-02-09
CZ25596A3 (en) 1996-07-17
NO308195B1 (no) 2000-08-14
HUT73500A (en) 1996-08-28
CN1130872A (zh) 1996-09-11
SK281895B6 (sk) 2001-09-11
NO960347L (no) 1996-03-07
PL312741A1 (en) 1996-05-13
ZA945431B (en) 1995-02-28
RO117149B1 (ro) 2001-11-30
BG100385A (bg) 1996-09-30
RU2160102C2 (ru) 2000-12-10
ATE207353T1 (de) 2001-11-15
AU7386194A (en) 1995-02-28
ITMI931673A0 (it) 1993-07-27
EP0711163A1 (en) 1996-05-15
JP3587851B2 (ja) 2004-11-10
IT1276040B1 (it) 1997-10-24
JPH09500385A (ja) 1997-01-14
SK10596A3 (en) 1997-03-05
AU692458B2 (en) 1998-06-11
WO1995003799A1 (en) 1995-02-09
SI0711163T1 (en) 2001-12-31
DK0711163T3 (da) 2001-11-26
LV11524B (en) 1996-12-20
DE69428797D1 (de) 2001-11-29
LV11524A (lv) 1996-10-20
DE69428797T2 (de) 2002-04-18
CN1085528C (zh) 2002-05-29
HU226805B1 (en) 2009-10-28
NO960347D0 (no) 1996-01-26
CA2167926C (en) 2004-12-21
EP0711163B1 (en) 2001-10-24

Similar Documents

Publication Publication Date Title
EP0947584A4 (en) Loxoprofen-containing preparation for external use
ITRM930399A0 (it) Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1263004B (it) Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
ITMI931673A1 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
IT1231509B (it) Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
IT1274026B (it) Composizione antitosse
IT1251838B (it) Uso della nimesulide nel trattamento della cataratta
IT1274157B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
NL990041I2 (nl) Oftalmische samenstellingen die combinaties van een carbonanhydrseremmer en een beta-adrenergische antagonist bevatten.
KR910009267A (ko) 우울증의 치료방법
EP0353474A3 (en) Glycerin derivative and its pharmacological use
IT7829429A0 (it) Preparato farmaceutico per la riduzione della produzione di ossalato e della sua precipitazione nell'urina.
ITRM930154A0 (it) Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
IT1299069B1 (it) Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")
IT1255039B (it) Impiego di l-carnitina nel trattamento di pazienti hiv-sieropositivi presentanti deficit di carnitina.
IT1291307B1 (it) Composizione farmaceutica atta al trattamento delle patologie neurodegenerative
GR3001613T3 (en) A "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) for use in therapy by topical application
BR9609937A (pt) Composição contendo ácido mefenâmico em associação com codeìna
IT8536364V0 (it) Staffa doppia per l'ancoraggio di tavole,particolarmente adatta perl'impiego nel settore edile
郑伯承 ZHANG ZHONGJING, THE SAGE OF CHINESE MEDICINE
IT8522851V0 (it) Griffa amovibile per l'ancoraggio del bicchiere al piatto nel consumo dei pasti in piedi senza tavoli.
IT1230627B (it) Composizioni farmaceutiche utili nel trattamento della ritenzione urinaria

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970724